II
ImmunityBio, Inc. - Common Stock
IBRX
Close · 12/11/2026
6.07
1D
-9.00%52-week range
1.95 – 12.43
Volume
2,10,24,000.00
Price history
IBRX
14/10/2026 to 12/11/2026
O 6.45 H 6.50 L 6.00
1W-24.22%
1M-38.75%
3M-19.82%
6M-25.52%
1Y+183.64%
3Y+67.22%
5Y-29.66%
MAX-38.62%
Fundamentals
as of 12/11/2026- Market cap
- $6.46B
- Shares out
- 1.06B
- P/E (forward)
- -54.73
- EPS (trailing)
- -1.04
- Dividend yield
- 0.00%
- Beta
- 0.17
- Profit margin
- -607.79%
- P/B
- -5.58
SEC financial statements
46 quarterly and 13 annual periods through 30/09/2026.
Details
- Ticker
- IBRX
- Index
- -
- Sector
- -
- Industry
- -
- HQ
- -
Last close 12/11/2026.
Tracked by Congress
2 filers · 0 on watchlist · 2 buys · 1 sell · ?: 1 · R: 2
- 30/09/2026Lisa McClainBuyImmunityBio, Inc. - Common Stock$1,001–$15,000
- 28/09/2026Lisa McClainBuyImmunityBio, Inc. - Common Stock$1,001–$15,000
- 06/03/2023Daniel GoldmanSellImmunityBio, Inc.$1,001–$15,000